Let’s again, take a look at their financials.
June 30/18
Cash and equivalents. $32 mil
Liabilities. $8.5 mil
Leaves them with $23.5 left.
Now in their last report, in the last 3 years they have used approximately $9.9 mil of their grants from Horizon and IIA. They were directly receiving $6.4 million from the Horizon,
Grants.
$6.4 million direct from Horizon
$3.3 mil IIA 2016
$1.4 mil IIA 2017
$900 g’s IIA 2018
$11.6 million total.
Anyone see a pattern to the size of the IIA grants?
That leaves them with $1.7 mil left via grants.
They have a grand total of approximately $25.2 left as of June 30th. And yes a quarter has passed, so maybe bring that down to around $20 mil. With grant money most likely gone already, quarterly cash used will be rising.
They’re going to need cash in the very near future. Could be down to $15 mil by eoy. What impact will that have on the share price?
Keep selling via the ATM? Do they want to add more pressure on the price? What will that do to the size and proceeds of the dilution if/when they pull that trigger?
Quite the predicament for our “experienced” twins. But they “got this”. Never had a problem finding investors to shaft in the past with their raises before. Getting funding is easy, free shares and big raises for the lucky few at the top. Well deserved.
A stockpiling contract would obviously help, but that seems to be less likely with each passing quarter. The delay in just getting the pivotal ARS study going is telling.
Why the sudden change of heart with our in house manufacturing prowess? Thermo collaboration is most likely to see if Thermo can benefit from Pluristem’s technology. That’s why terms will be discussed later imo. If Thermo does find a use, could give the company some cash. But with an imminent stockpiling agreement to occur by the end of 2017, why now, after more than a decade of keeping it all to ourselves.
But shareholders don’t deserve to know what’s going on at all. Just keep us informed with the same presentation time and time again. Take out the milestones to try and save face.
Why inform them of enrolment numbers for their trial. There was a reason for that during the IC trials. Recruitment was agonizingly slow. But CLI will be different. Should be halfway through our trials by now right.
Pretend not to read anything beyond the first couple sentences. Pretend you couldn’t make out the “gibberish”. Look for a misplaced comma though, or a typo. That keeps “hopes” alive, when reality says otherwise.
Once ROctober’s done, we still have NoNovember and DUDecember left to truly make 2017 errr 2018 “THE YEAR OF THE SHAREHOLDER”. As Rocking Zami walks in to the board meeting, both hands raised with the sign of the horns, as board members slurp back matzah ball soup and toast with a glass of Cristal.
